FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to ophthalmology, and can be used for surgical treatment of progressing and complicated myopia. As scleroplastic material implanted is three-component complex, which contains mesenchymal stem cells, labeled with magnetic microparticles. Cells are translocated into biological or synthetic fine-porous material, which is tightly connected with polymer magnetic material with induction of constant magnetic field 1.5 mT, with multi-polar reversible magnetisation.
EFFECT: invention ensures enhancement of strength-elastic properties of sclera, stabilisation of myopic process with simultaneous prevention of development of dystrophic changes of eye fundus or further progressing in case of their presence.
1 ex
Title | Year | Author | Number |
---|---|---|---|
THREE-COMPONENT COMPLEX FOR CELL THERAPY IN OPHTHALMOLOGY | 2012 |
|
RU2495650C1 |
METHOD OF TREATING "DRY" FORM OF AGE-RELATED MACULAR DEGENERATION | 2012 |
|
RU2485922C1 |
METHOD OF TREATING OPTIC NERVE ATROPHY OF DIFFERENT ETIOLOGY | 2012 |
|
RU2494712C1 |
METHOD OF TREATING "DRY" FORM OF AGE-SPECIFIC MACULAR DEGENERATION | 2011 |
|
RU2470619C1 |
METHOD OF TREATING "DRY" FORM OF AGE-RELATED MACULAR DEGENERATION | 2011 |
|
RU2471458C1 |
METHOD OF TREATING OPTIC NERVE ATROPHY OF DIFFERENT ETIOLOGY | 2011 |
|
RU2482823C2 |
REINFORCED TRANSPLANT FOR SCLEROPLASTIC OPERATIONS | 1998 |
|
RU2140242C1 |
IMPLANT FOR OPERATIONS ON IMPROVING HUMAN EYE COVERS | 2014 |
|
RU2579281C1 |
TRANSPLANT FOR SCLEROPLASTY | 2010 |
|
RU2458663C1 |
SURGICAL METHOD FOR TREATING DYSTROPHIC CHANGES IN RETINA AND CHOROIDEA IN COMPLICATED MYOPIA CASES | 2003 |
|
RU2250093C1 |
Authors
Dates
2013-10-10—Published
2012-05-18—Filed